Education
About Us
Working with TipRanks
Follow Us
10x Genomics Inc (TXG)
NASDAQ:TXG
TXG Analyst Ratings
Moderate Buy
4 Buy
6 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
TXG Stock 12 Month Forecast
Average Price Target
$13.44
▼(-2.11%Downside)
| Highest Price Target$18.00 | Average Price Target$13.44 | Lowest Price Target$9.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
$14
Hold
1.97%
Upside
Reiterated
07/23/25
10x Genomics faces profitability challenges with consistent net losses and a negative P/E ratio, impacting its overall score. While the stock demonstrates positive technical momentum and strong gross margins, uncertainties in revenue guidance and U.S. funding pressures weigh heavily. Despite these issues, the company's strategic focus on product innovation and cost reduction provides some optimism for long-term growth.
Leerink Partners
$12→$15
Hold
9.25%
Upside
Reiterated
07/17/25
TD Cowen
$11
Hold
-19.88%
Downside
Reiterated
07/15/25
Canaccord Genuity
$15
Buy
9.25%
Upside
Reiterated
06/30/25
Bank of America Securities
$12→$13
Hold
-5.32%
Downside
Reiterated
06/26/25
Barclays
$12→$13
Buy
-5.32%
Downside
Reiterated
06/24/25
Morgan Stanley
$18
Buy
31.10%
Upside
Reiterated
05/19/25
William Blair
―
Hold
―
Reiterated
05/14/25
UBS
$14→$12
Hold
-12.60%
Downside
Reiterated
05/13/25
J.P. Morgan
$12→$9
Hold
-34.45%
Downside
Reiterated
05/09/25
Stifel Nicolaus
$18→$15
Buy
9.25%
Upside
Reiterated
05/09/25
Citi
$20→$15
Buy
9.25%
Upside
Reiterated
03/04/25
Guggenheim
―
Hold
―
Reiterated
02/23/25
We expect TXG to share more on what these new products will mean for the research community and their competitive positioning at AGBT, especially given other updates from the likes of BRKR and ILMN heading into the conference. *** We will be attending AGBT in person. If you are there and want to meet, let us know. Also, please email us if you want to schedule a time to chat after.
Jefferies
$19
Buy
38.38%
Upside
Reiterated
02/12/25
Goldman Sachs
$16→$14
Sell
1.97%
Upside
Reiterated
10/30/24
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
$14
Hold
1.97%
Upside
Reiterated
07/23/25
10x Genomics faces profitability challenges with consistent net losses and a negative P/E ratio, impacting its overall score. While the stock demonstrates positive technical momentum and strong gross margins, uncertainties in revenue guidance and U.S. funding pressures weigh heavily. Despite these issues, the company's strategic focus on product innovation and cost reduction provides some optimism for long-term growth.
Leerink Partners
$12→$15
Hold
9.25%
Upside
Reiterated
07/17/25
TD Cowen
$11
Hold
-19.88%
Downside
Reiterated
07/15/25
Canaccord Genuity
$15
Buy
9.25%
Upside
Reiterated
06/30/25
Bank of America Securities
$12→$13
Hold
-5.32%
Downside
Reiterated
06/26/25
Barclays
$12→$13
Buy
-5.32%
Downside
Reiterated
06/24/25
Morgan Stanley
$18
Buy
31.10%
Upside
Reiterated
05/19/25
William Blair
―
Hold
―
Reiterated
05/14/25
UBS
$14→$12
Hold
-12.60%
Downside
Reiterated
05/13/25
J.P. Morgan
$12→$9
Hold
-34.45%
Downside
Reiterated
05/09/25
Stifel Nicolaus
$18→$15
Buy
9.25%
Upside
Reiterated
05/09/25
Citi
$20→$15
Buy
9.25%
Upside
Reiterated
03/04/25
Guggenheim
―
Hold
―
Reiterated
02/23/25
We expect TXG to share more on what these new products will mean for the research community and their competitive positioning at AGBT, especially given other updates from the likes of BRKR and ILMN heading into the conference. *** We will be attending AGBT in person. If you are there and want to meet, let us know. Also, please email us if you want to schedule a time to chat after.
Jefferies
$19
Buy
38.38%
Upside
Reiterated
02/12/25
Goldman Sachs
$16→$14
Sell
1.97%
Upside
Reiterated
10/30/24
Best Analysts Covering 10x Genomics
1 Month
xxx
Success Rate
9/19 ratings generated profit
Average Return
-2.76%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 47.37% of your transactions generating a profit, with an average return of -2.76% per trade.
3 Months
xxx
Success Rate
8/19 ratings generated profit
Average Return
-4.59%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 42.11% of your transactions generating a profit, with an average return of -4.59% per trade.
1 Year
Success Rate
9/19 ratings generated profit
Average Return
+6.64%
reiterated a buy rating 5 months ago
Copying Patrick B Donnelly's trades and holding each position for 1 Year would result in 47.37% of your transactions generating a profit, with an average return of +6.64% per trade.
2 Years
xxx
Success Rate
6/22 ratings generated profit
Average Return
-15.24%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 27.27% of your transactions generating a profit, with an average return of -15.24% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
TXG Analyst Recommendation Trends
Rating
Mar 25
Apr 25
May 25
Jun 25
Jul 25
Strong Buy
6
6
4
4
3
Buy
5
3
2
3
3
Hold
8
6
13
16
21
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
19
15
19
23
27
Each month's total comprises the sum of three months' worth of ratings.
TXG Financial Forecast
TXG Stock Forecast FAQ
What is TXG’s average 12-month price target, according to analysts?
Based on analyst ratings, 10x Genomics Inc’s 12-month average price target is 13.44.
What is TXG’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for TXG, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is TXG a Buy, Sell or Hold?
10x Genomics Inc has a consensus rating of Moderate Buy which is based on 4 buy ratings, 6 hold ratings and 0 sell ratings.
What is 10x Genomics Inc’s price target?
The average price target for 10x Genomics Inc is 13.44. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $18.00 ,the lowest forecast is $9.00. The average price target represents -2.11% Decrease from the current price of $13.73.
The highest analyst price target is $18.00 ,the lowest forecast is $9.00. The average price target represents -2.11% Decrease from the current price of $13.73.
What do analysts say about 10x Genomics Inc?
10x Genomics Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 10 Wall Streets Analysts.
How can I buy shares of TXG?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.